Compare Amphastar Pharmaceuticals Inc (AMPH) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Pinterest Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while Pinterest Inc trades at $23.67 (market cap $13.80B). The key difference: Pinterest Inc is far larger — about 16× Amphastar Pharmaceuticals Inc's market cap, and Pinterest Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | PINS | |
|---|---|---|
Market Cap | $863.95M | $13.80B |
Sector | Health | Media |
52-Week High | $30.81 | $37.95 |
52-Week Low | $16.87 | $15.42 |
Enterprise Value | $1.26B | $13.72B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
Pinterest (PINS) trades at $23.68, up 1.46% on the day, with a bullish technical signal from moving averages and strong fundamental revenue growth of 18% year-over-year in Q2 2026. The company has consistently beaten earnings estimates, with Q2 EPS of $0.43 surpassing the $0.36 consensus, driven by AI-powered ad growth and record monthly active users. However, net cash flow remains negative, and the stock faces headwinds from intense ad competition and lukewarm sales guidance.
The outlook is cautiously optimistic, with a consensus price target of $28.69 offering ~21% upside. Investment opportunities include sustained user growth and AI monetization, but risks involve competitive pressures from Meta's Instagram and volatility from insider selling, such as the CFO's $1.39 million stock sale on August 7, 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
